ECG Optimization of CRT: Evaluation of Mid-term Response
Launched by HOSPITAL CLINIC OF BARCELONA · Sep 22, 2011
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: patients with standard indication of cardiac resynchronization
- • Ejection fraction ≤35%.
- • QRS duration ≥120 ms.
- • New York Heart Association Functional Class 2-4..
- • Left ventricular diameter ≥55 mm.
- • Optimal medical treatment.
- Exclusion Criteria:
- • Patient refusal.
- • Cardiopathy with a reversible cause.
- • Prevision of heart transplantation.
- • Atrial fibrillation.
- • Complete AV block.
- • AV delay \>250 ms.
- • Right bundle branch block.
- • Severe peripheral vascular disease.
- • Other diseases with \< 1 year life expectancy
About Hospital Clinic Of Barcelona
The Hospital Clinic of Barcelona is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry to enhance patient outcomes. As a prominent sponsor of clinical trials, the Hospital Clinic of Barcelona is dedicated to exploring new therapies and treatment modalities across various medical fields, fostering a culture of excellence in clinical research that ultimately aims to improve the quality of care for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Trial Officials
Elena Arbelo, MD, PhD
Study Chair
Hospital Clinic Universitari de Barcelona
Lluís Mont, MD, PhD
Study Director
Hospital Clínic Universitari de Barcelona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials